A polymorphism at IGF1 locus is associated with anemia

Oncotarget

Volumn 8, Issue 20, 2017, Pages 32398-32406

  Marini, Maria Adelaide ^a   Mannino, Gaia Chiara ^b   Fiorentino, Teresa Vanessa ^b   Andreozzi, Francesco ^b   Perticone, Francesco ^b   Sesti, Giorgio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Anemia; Hemoglobin; Insulin like growth factor 1; Pathology Section; Rs35767; Single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PIOGLITAZONE; SARTAN DERIVATIVE; SOMATOMEDIN C;

ADULT; AGE; ALLELE; ANEMIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IGF1 GENE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WAIST CIRCUMFERENCE; BLOOD; ERYTHROPOIESIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ANEMIA; ERYTHROPOIESIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85019261258     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.16132     Document Type: Article

References (40)

1. Beghé C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A: 3S-10S. doi: 10.1016/j. amjmed.2003.12.009
2. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PHM, Newman AB, Cushman M. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med. 2005; 165: 2214-20. doi: 10.1001/archinte.165.19.2214
3. Thomas MC, MacIsaac RJ, Tsalamandris C, Molyneaux L, Goubina I, Fulcher G, Yue D, Jerums G. The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dial Transplant. 2004; 19: 1792-7. doi: 10.1093/ndt/gfh248
4. Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, Ma RC, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care. 2006; 29: 2439-44. doi: 10.2337/dc06-0887
5. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003; 114: 112-9
6. Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013; 165: 143-153.e5. doi: 10.1016/j. ahj.2012.10.024
7. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003; 107: 223-5
8. Anand I, McMurray JJV, Whitmore J, Warren M, Pham A, McCamish MA, Burton PBJ. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004; 110: 149-54. doi: 10.1161/01.CIR.0000134279.79571.73
9. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis Off J Natl Kidney Found. 1996; 28: 53-61
10. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659-63. doi: 10.1001/archinte.164.6.659
11. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002; 40: 27-33
12. Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood. 1991; 78: 2823-33
13. Claustres M, Chatelain P, Sultan C. Insulin-like growth factor I stimulates human erythroid colony formation in vitro. J Clin Endocrinol Metab. 1987; 65: 78-82. doi: 10.1210/jcem-65-1-78
14. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest. 1989; 83: 1701-9. doi: 10.1172/JCI114070
15. Ratajczak J, Zhang Q, Pertusini E, Wojczyk BS, Wasik MA, Ratajczak MZ. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions-comparison to other cytokines and growth factors. Leukemia. 1998; 12: 371-81
16. Miyagawa S, Kobayashi M, Konishi N, Sato T, Ueda K. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Br J Haematol. 2000; 109: 555-62
17. Anttila R, Koistinen R, Seppälä M, Koistinen H, Siimes MA. Insulin-like growth factor I and insulin-like growth factor binding protein 3 as determinants of blood hemoglobin concentration in healthy subjects. Pediatr Res. 1994; 36: 745-8. doi: 10.1203/00006450-199412000-00011
18. Nilsson-Ehle H, Bengtsson BA, Lindstedt G, Mellström D. Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects. Eur J Haematol. 2005; 74: 111-6. doi: 10.1111/j.1600-0609.2004.00374.x
19. Succurro E, Arturi F, Caruso V, Rudi S, Sciacqua A, Andreozzi F, Hribal ML, Perticone F, Sesti G. Low insulinlike growth factor-1 levels are associated with anaemia in adult non-diabetic subjects. Thromb Haemost. 2011; 105: 365-70. doi: 10.1160/TH10-06-0379
20. De Vita F, Maggio M, Lauretani F, Crucitti L, Bandinelli S, Mammarella F, Landi F, Ferrucci L, Ceda GP. INSULINLIKE GROWTH FACTOR-1 AND ANEMIA IN OLDER SUBJECTS: THE INCHIANTI STUDY. Endocr Pract. 2015; 21:1211-8
21. Iglesias P, Díez JJ, Fernández-Reyes MJ, Aguilera A, Burgués S, Martínez-Ara J, Miguel JL, Gómez-Pan A, Selgas R. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am J Kidney Dis. 1998; 32: 454-63
22. Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, Chiu KC, Ng P. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab. 2001; 86: 1913-20. doi: 10.1210/jcem.86.5.7457
23. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer. 2006; 94: 299-307. doi: 10.1038/sj.bjc.6602936
24. Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, Holly J, Fentiman IS, Silva I dos S, Ashworth A, Peto J, Fletcher O. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet. 2008; 17: 1457-64. doi: 10.1093/hmg/ddn034
25. Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PloS One. 2008; 3: e2578. doi: 10.1371/journal. pone.0002578
26. Ollberding NJ, Cheng I, Wilkens LR, Henderson BE, Pollak MN, Kolonel LN, Le Marchand L. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study. Cancer Epidemiol Biomarkers Prev. 2012; 21: 810-20. doi: 10.1158/1055-9965.EPI-11-1105
27. Mannino GC, Greco A, De Lorenzo C, Andreozzi F, Marini MA, Perticone F, Sesti G. A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. PloS One. 2013; 8: e85483. doi: 10.1371/journal.pone.0085483
28. Sesti G, Mannino GC, Andreozzi F, Greco A, Perticone M, Sciacqua A, Marini MA, Perticone F. A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. Atherosclerosis. 2014; 232: 25-30. doi: 10.1016/j. atherosclerosis.2013.10.024
29. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Mägi R, Morris AP, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-16. doi: 10.1038/ng.520
30. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppälä M. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 1996; 98: 2612-5. doi: 10.1172/JCI119081
31. Telgmann R, Dördelmann C, Brand E, Nicaud V, Hagedorn C, Pavenstädt H, Cambien F, Tiret L, Paul M, Brand-Herrmann SM. Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation. FASEB J. 2009; 23: 1303-13. doi: 10.1096/fj.08-116863
32. Maggio M, De Vita F, Fisichella A, Lauretani F, Ticinesi A, Ceresini G, Cappola A, Ferrucci L, Ceda GP. The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones. Int J Endocrinol. 2015; 2015: 292574. doi: 10.1155/2015/292574
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9
34. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968; 405: 5-37
35. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-12
36. Hribal ML, Procopio T, Petta S, Sciacqua A, Grimaudo S, Pipitone RM, Perticone F, Sesti G. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2013; 98: E304-308. doi: 10.1210/jc.2012-3290
37. Federici M, Porzio O, Zucaro L, Fusco A, Borboni P, Lauro D, Sesti G. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol Cell Endocrinol. 1997; 129: 121-6
38. Dallman PR, Yip R, Johnson C. Prevalence and causes of anemia in the United States, 1976 to 1980. Am J Clin Nutr. 1984; 39: 437-45
39. Meyers LD, Habicht JP, Johnson CL, Brownie C. Prevalences of anemia and iron deficiency anemia in Black and White women in the United States estimated by two methods. Am J Public Health. 1983; 73: 1042-9
40. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006; 107: 1747-50. doi: 10.1182/blood-2005-07-3046